Transforming growth factor-β in normal nociceptive processing and pathological pain models

Molecular Neurobiology

Volumn 45, Issue 1, 2012, Pages 76-86

  Lantero, Aquilino ^a,b   Tramullas, Mónica ^a,b   Díaz, Alvaro ^a,c,d   Hurlé, María A ^a,b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c University of Cantabria   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Activin; BAMBI; BMP; Neuropathic pain; Nociception; Pain; TGF

Indexed keywords

ACTIVIN; BAMBI PROTEIN; BONE MORPHOGENETIC PROTEIN; ENDORPHIN; INHIBITOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

GENE EXPRESSION REGULATION; GLIA; HUMAN; IMMUNE RESPONSE; NERVOUS SYSTEM; NEUROPATHIC PAIN; NEUROPROTECTION; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; PATHOPHYSIOLOGY; PEPTIDERGIC NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM; PLEIOTROPY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD; TISSUE REPAIR; WOUND HEALING;

EID: 84856745428     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-011-8221-1     Document Type: Review

References (76)

1. AM Elliott BH Smith KI Penny WC Smith WA Chambers 1999 The epidemiology of chronic pain in the community Lancet 354 1248 1252 10.1016/S0140-6736(99) 03057-3 10520633 10.1016/S0140-6736(99)03057-3 1:STN:280:DyaK1MvkvV2nsQ%3D%3D (Pubitemid 29469353)
2. H Breivik B Collett V Ventafridda R Cohen D Gallacher 2006 Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment Eur J Pain 10 287 333 10.1016/j.ejpain.2005.06.009 16095934 10.1016/j.ejpain.2005.06. 009
3. K Wharton R Derynck 2009 TGFbeta family signaling: novel insights in development and disease Development 136 3691 3697 10.1242/dev.040584 19855012 10.1242/dev.040584 1:CAS:528:DC%2BD1MXhsFyltrrL
4. B Schmierer CS Hill 2007 TGFβ-Smad signal transduction: molecular specificity and functional flexibility Nat Rev Mol Cell Biol 8 970 982 10.1038/nrm2297 18000526 10.1038/nrm2297 1:CAS:528:DC%2BD2sXhtlCrsb3K (Pubitemid 350174642)
5. K Miyazono S Maeda T Imamura 2005 BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk Cytokine Growth Factor Rev 16 251 263 10.1016/j.cytogfr.2005.01.009 15871923 10.1016/j.cytogfr.2005. 01.009 1:CAS:528:DC%2BD2MXlsl2rtL0%3D (Pubitemid 40910315)
6. YE Zhang 2009 Non-Smad pathways in TGF-beta signaling Cell Res 19 128 139 10.1038/cr.2008.328 19114990 10.1038/cr.2008.328 1:CAS:528: DC%2BD1MXht1GhsQ%3D%3D
7. JS Kang C Liu R Derynck 2009 New regulatory mechanisms of TGF-beta receptor function Trends Cell Biol 19 385 394 10.1016/j.tcb.2009.05.008 19648010 10.1016/j.tcb.2009.05.008 1:CAS:528:DC%2BD1MXhtVSitLjF
8. A Moustakas CH Heldin 2009 The regulation of TGFbeta signal transduction Development 136 22 3699 3714 10.1242/dev.030338 19855013 10.1242/dev.030338 1:CAS:528:DC%2BD1MXhsFyltrrE
9. D Umulis MB O'Connor SS Blair 2009 The extracellular regulation of bone morphogenetic protein signaling Development 136 3715 3728 10.1242/dev.031534 19855014 10.1242/dev.031534 1:CAS:528:DC%2BD1MXhsFyltrrF
10. D Onichtchouk YG Chen R Dosch V Gawantka H Delius J Massagué C Niehrs 1999 Silencing of TGF-beta signalling by the pseudoreceptor BAMBI Nature 401 480 485 10.1038/46794 10519551 10.1038/46794 1:CAS:528:DyaK1MXmslyqsrY%3D (Pubitemid 29470206)
11. S Itoh P ten Dijke 2007 Negative regulation of TGF-b receptor/Smad signal transduction Curr Opin Cell Biol 19 176 184 10.1016/j.ceb.2007.02.015 17317136 10.1016/j.ceb.2007.02.015 1:CAS:528:DC%2BD2sXjt1Slu7Y%3D (Pubitemid 46386411)
12. AI Basbaum DM Bautista G Scherrer D Julius 2009 Cellular and molecular mechanisms of pain Cell 139 267 284 10.1016/j.cell.2009.09.028 19837031 10.1016/j.cell.2009.09.028 1:CAS:528:DC%2BD1MXhsFWht7zI
13. F Cervero 2009 Pain: friend or foe? A neurobiologic perspective: the 2008 Bonica Award Lecture Reg Anesth Pain Med 34 569 574 10.1097/AAP. 0b013e3181b4c517 19916249 10.1097/AAP.0b013e3181b4c517 1:CAS:528: DC%2BD1MXhsFaqtbvE
14. D Bouhassira M Lantéri-Minet N Attal B Laurent C Touboul 2008 Prevalence of chronic pain with neuropathic characteristics in the general population Pain 136 380 387 10.1016/j.pain.2007.08.013 17888574 10.1016/j.pain.2007.08.013 (Pubitemid 351680253)
15. R D'Mello AH Dickenson 2008 Spinal cord mechanisms of pain Br J Anaesth 101 8 16 10.1093/bja/aen088 18417503 10.1093/bja/aen088 (Pubitemid 351881902)
16. M Costigan J Scholz CJ Woolf 2009 Neuropathic pain: a maladaptive response of the nervous system to damage Annu Rev Neurosci 32 1 32 10.1146/annurev.neuro.051508.135531 19400724 10.1146/annurev.neuro.051508.135531 1:CAS:528:DC%2BD1MXpsV2nur8%3D
17. F Cervero 2009 Spinal cord hyperexcitability and its role in pain and hyperalgesia Exp Brain Res 196 129 137 10.1007/s00221-009-1789-2 19350227 10.1007/s00221-009-1789-2
18. ED Milligan LR Watkins 2009 Pathological and protective roles of glia in chronic pain Nat Rev Neurosci 10 23 36 10.1038/nrn2533 19096368 10.1038/nrn2533 1:CAS:528:DC%2BD1MXpt1ek
19. PJ Austin G Moalem-Taylor 2010 The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines J Neuroimmunol 229 26 50 10.1016/j.jneuroim.2010.08.013 20870295 10.1016/j.jneuroim.2010.08.013 1:CAS:528:DC%2BC3cXhsVGitr3F
20. M Tramullas A Lantero A Díaz N Morchón D Merino A Villar D Buscher R Merino JM Hurlé JC Izpisúa-Belmonte MA Hurlé 2010 BAMBI (bone morphogenetic protein and activin membrane-bound inhibitor) reveals the involvement of the transforming growth factor-beta family in pain modulation J Neurosci 30 1502 1511 10.1523/JNEUROSCI.2584-09.2010 20107078 10.1523/JNEUROSCI.2584-09.2010 1:CAS:528:DC%2BC3cXhsVOqsr0%3D
21. S Kamphuis A Kavelaars R Brooimans W Kuis BJ Zegers CJ Heijnen 1997 T helper 2 cytokines induce preproenkephalin mRNA expression and proenkephalin A in human peripheral blood mononuclear cells J Neuroimmunol 79 91 99 10.1016/S0165-5728(97)00113-6 9357452 10.1016/S0165-5728(97)00113-6 1:CAS:528:DyaK2sXlsFGltrw%3D (Pubitemid 27454688)
22. M Nudi JF Ouimette J Drouin 2005 Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity Mol Endocrinol 19 1329 1342 10.1210/me.2004-0425 15695370 10.1210/me.2004-0425 1:CAS:528:DC%2BD2MXktFent7w%3D (Pubitemid 40594128)
23. S Echeverry XQ Shi A Haw H Liu ZW Zhang J Zhang 2009 Transforming growth factor-beta1 impairs neuropathic pain through pleiotropic effects Mol Pain 5 16 10.1186/1744-8069-5-16 19327151 10.1186/1744-8069-5-16
24. IS McLennan MW Weible 2nd IA Hendry K Koishi 2005 Transport of transforming growth factor-beta 2 across the blood-brain barrier Neuropharmacology 48 274 282 10.1016/j.neuropharm.2004.10.005 15695166 10.1016/j.neuropharm.2004.10.005 1:CAS:528:DC%2BD2MXhtFOksL8%3D (Pubitemid 40208263)
25. M Bottner K Krieglstein K Unsicker 2000 The TGF-βs: structure, signalling and roles in nervous system development and functions J Neurochem 75 2227 2240 10.1046/j.1471-4159.2000.0752227.x 11080174 10.1046/j.1471-4159.2000. 0752227.x 1:CAS:528:DC%2BD3cXotFKgtb0%3D
26. TC Brionne I Tesseur E Masliah T Wyss-Coray 2003 Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain Neuron 40 1133 1145 10.1016/S0896-6273(03)00766-9 14687548 10.1016/S0896-6273(03)00766-9 1:CAS:528:DC%2BD2cXhtVGqsw%3D%3D (Pubitemid 38032790)
27. PT Ronaldson KM Demarco L Sanchez-Covarrubias CM Solinsky TP Davis 2009 Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain J Cereb Blood Flow Metab 29 1084 1098 10.1038/jcbfm.2009.32 19319146 10.1038/jcbfm.2009.32 1:CAS:528:DC%2BD1MXntVyku7k%3D
28. PT Ronaldson JD Finch KM Demarco CE Quigley TP Davis 2011 Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier J Pharmacol Exp Ther 336 827 839 10.1124/jpet.110.174151 21131267 10.1124/jpet.110.174151 1:CAS:528: DC%2BC3MXivVKqt7o%3D
29. S Echeverry XQ Shi S Rivest J Zhang 2011 Peripheral nerve injury alters blood-spinal cord barrier functional and molecular integrity through a selective inflammatory pathway J Neurosci 31 10819 11028 10.1523/JNEUROSCI.1642-11.2011 21795534 10.1523/JNEUROSCI.1642-11.2011 1:CAS:528:DC%2BC3MXhtVSitrbJ
30. AE Dmitriev S Farhang RA Lehman Jr GS Ling AJ Symes 2010 Bone morphogenetic protein-2 used in spinal fusion with spinal cord injury penetrates intrathecally and elicits a functional signaling cascade Spine J 10 16 25 10.1016/j.spinee.2009.10.003 19914878 10.1016/j.spinee.2009.10.003
31. AE Dmitriev RA Lehman Jr AJ Symes 2011 Bone morphogenetic protein-2 and spinal arthrodesis: the basic science perspective on protein interaction with the nervous system Spine J 11 500 505 10.1016/j.spinee.2011.05.002 21729799 10.1016/j.spinee.2011.05.002
32. EJ Carragee EL Hurwitz BK Weiner 2011 A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned Spine J 11 471 491 10.1016/j.spinee.2011.04.023 21729796 10.1016/j.spinee.2011.04.023
33. SD Glassman JL Gum CH Crawford 3rd CB Shields LY Carreon 2011 Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear Spine J 11 522 526 10.1016/j.spinee.2010.05.016 20598649 10.1016/j.spinee.2010.05.016
34. CP Hofstetter NA Holmström JA Lilja P Schweinhardt J Hao C Spenger Z Wiesenfeld-Hallin SN Kurpad J Frisén L Olson 2005 Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome Nat Neurosci 8 346 353 10.1038/nn1405 15711542 10.1038/nn1405 1:CAS:528:DC%2BD2MXhslyqsLY%3D (Pubitemid 40300192)
35. MY Macias MB Syring MA Pizzi MJ Crowe AR Alexanian SN Kurpad 2006 Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury Exp Neurol 201 335 348 10.1016/j.expneurol.2006.04.035 16839548 10.1016/j.expneurol.2006.04.035 1:CAS:528:DC%2BD28XpslSmtbY%3D (Pubitemid 44344226)
36. JE Davies C Pröschel N Zhang M Noble M Mayer-Pröschel SJ Davies 2008 Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury J Biol 7 24 10.1186/jbiol85 18803859 10.1186/jbiol85
37. SJ Davies CH Shih M Noble M Mayer-Proschel JE Davies C Proschel 2011 Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury PLoS One 6 e17328 10.1371/journal.pone.0017328 21407803 10.1371/journal.pone.0017328 1:CAS:528:DC%2BC3MXjtl2lsbs%3D
38. S Maeda A Kawamoto Y Yatani H Shirakawa T Nakagawa S Kaneko 2008 Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats Mol Pain 4 65 10.1186/1744-8069-4-65 19108711 10.1186/1744-8069-4-65
39. YK Choi JH Kim WJ Kim HY Lee JA Park SW Lee DK Yoon HH Kim H Chung YS Yu 2007 Kim KW (2007) AKAP12 regulates human blood-retinal barrier formation by downregulation of hypoxia-inducible factor-1alpha J Neurosci 27 4472 4481 10.1523/JNEUROSCI.5368-06.2007 17442832 10.1523/JNEUROSCI.5368-06.2007 1:CAS:528:DC%2BD2sXkvFCjt7k%3D (Pubitemid 46640706)
40. P Parikh Y Hao M Hosseinkhani SB Patil GW Huntley M Tessier-Lavigne H Zou 2011 Regeneration of axons in injured spinal cord by activation of bone morphogenetic protein/Smad1 signaling pathway in adult neurons Proc Natl Acad Sci U S A 108 E99 E107 10.1073/pnas.1100426108 21518886 10.1073/pnas.1100426108
41. MJ Tsai HA Pan DY Liou CF Weng BJ Hoffer H Cheng 2010 Adenoviral gene transfer of bone morphogenetic protein-7 enhances functional recovery after sciatic nerve injury in rats Gene Ther 17 1214 1224 10.1038/gt.2010.72 20520648 10.1038/gt.2010.72 1:CAS:528:DC%2BC3cXmvFWlu74%3D
42. S Hippenmeyer I Kramer S Arber 2004 Control of neuronal phenotype: what targets tell the cell bodies Trends Neurosci 27 482 488 10.1016/j.tins.2004.05. 012 15271496 10.1016/j.tins.2004.05.012 1:CAS:528:DC%2BD2cXmtVahtrk%3D (Pubitemid 38951041)
43. S Sanyal SM Kim M Ramaswami 2004 Retrograde regulation in the CNS; neuron-specific interpretations of TGF-beta signaling Neuron 41 845 848 10.1016/S0896-6273(04)00152-7 15046717 10.1016/S0896-6273(04)00152-7 1:CAS:528:DC%2BD2cXjtValtL4%3D (Pubitemid 38429728)
44. EA Lumpkin MJ Caterina 2007 Mechanisms of sensory transduction in the skin Nature 445 858 865 10.1038/nature05662 17314972 10.1038/nature05662 1:CAS:528:DC%2BD2sXhvFGiu7Y%3D
45. X Ai J Cappuzzello AK Hall 1999 Activin and bone morphogenetic proteins induce calcitonin gene-related peptide in embryonic sensory neurons in vitro Mol Cell Neurosci 14 506 518 10.1006/mcne.1999.0798 10656256 10.1006/mcne.1999.0798 1:CAS:528:DC%2BD3cXit1amsA%3D%3D (Pubitemid 30026591)
46. AK Hall RM Burke M Anand KJ Dinsio 2002 Activin and bone morphogenetic proteins are present in perinatal sensory neuron target tissues that induce neuropeptides J Neurobiol 52 52 60 10.1002/neu.10068 12115893 10.1002/neu.10068 1:CAS:528:DC%2BD38Xlsl2ltr8%3D (Pubitemid 34666129)
47. D Zhang MF Mehler Q Song JA Kessler 1998 Development of bone morphogenetic protein receptors in the nervous system and possible roles in regulating trkC expression J Neurosci 18 3314 3326 10.1002/neu.10068 9547239 1:CAS:528:DyaK1cXivFCgtr4%3D (Pubitemid 28186023)
48. W Zhu P Xu FX Cuascut AK Hall GS Oxford 2007 Activin acutely sensitizes dorsal root ganglion neurons and induces hyperalgesia via PKC-mediated potentiation of transient receptor potential vanilloid I J Neurosci 27 13770 13780 10.1523/JNEUROSCI.3822-07.2007 18077689 10.1523/JNEUROSCI.3822-07.2007 1:CAS:528:DC%2BD1cXmsVA%3D (Pubitemid 350278254)
49. G Winnier M Blessing PA Labosky BL Hogan 1995 Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse Genes Dev 9 2105 2116 10.1101/gad.9.17.2105 7657163 10.1101/gad.9.17.2105 1:CAS:528:DyaK2MXotVOnu7w%3D
50. H Takahashi T Ikeda 1996 Transcripts for two members of the transforming growth factor-beta superfamily BMP-3 and BMP-7 are expressed in developing rat embryos Dev Dyn 207 439 449 10.1002/(SICI)1097-0177(199612 8950518 10.1002/(SICI)1097-0177(199612)207:4<439::AID-AJA8>3.0.CO;2-I 1:CAS:528:DyaK2sXot1Gr (Pubitemid 26399232)
51. LC Yu JF Hou FH Fu YX Zhang 2009 Roles of calcitonin gene-related peptide and its receptors in pain-related behavioral responses in the central nervous system Neurosci Biobehav Rev 33 1185 1191 10.1016/j.neubiorev.2009.03.009 19747596 10.1016/j.neubiorev.2009.03.009 1:CAS:528:DC%2BD1MXhtFajsbzF
52. AK Hall X Ai GE Hickman SE MacPhedran CO Nduaguba CP Robertson 1997 The generation of neuronal heterogeneity in a rat sensory ganglion J Neurosci 17 2775 2784 9092599 1:CAS:528:DyaK2sXisValtb0%3D (Pubitemid 27155011)
53. E Marti SJ Gibson JM Polak P Facer DR Springall G Van Aswegen M Aitchison M Koltzenburg 1987 Ontogeny of peptide- and amine-containing neurones in motor, sensory, and autonomic regions of rat and human spinal cord, dorsal root ganglia, and rat skin J Comp Neurol 266 332 359 2447134 10.1002/cne.902660304 1:STN:280:DyaL1c%2FovVSgtw%3D%3D (Pubitemid 18003969)
54. AK Hall KJ Dinsio J Cappuzzello 2001 Skin cell induction of calcitonin gene-related peptide in embryonic sensory neurons in vitro involves activin Dev Biol 229 263 270 10.1006/dbio.2000.9966 11203694 10.1006/dbio.2000.9966 1:CAS:528:DC%2BD3MXnvFKisw%3D%3D (Pubitemid 32108690)
55. MA Hamza DM Higgins WT Ruyechan 2007 Two alphaherpesvirus latency-associated gene products influence calcitonin gene-related peptide levels in rat trigeminal neurons Neurobiol Dis 25 553 560 10.1016/j.nbd.2006.10. 016 17184994 10.1016/j.nbd.2006.10.016 1:CAS:528:DC%2BD2sXisVWiur0%3D
56. BA Cruise P Xu AK Hall 2004 Wounds increase activin in skin and a vasoactive neuropeptide in sensory ganglia Dev Biol 271 1 10 10.1016/j.ydbio.2004.04.003 15196945 10.1016/j.ydbio.2004.04.003 1:CAS:528:DC%2BD2cXkvVCksLg%3D (Pubitemid 38757770)
57. P Xu C Van Slambrouck L Berti-Mattera AK Hall 2005 Activin induces tactile allodynia and increases calcitonin gene-related peptide after peripheral inflammation J Neurosci 25 9227 9235 10.1523/JNEUROSCI.3051-05.2005 16207882 10.1523/JNEUROSCI.3051-05.2005 1:CAS:528:DC%2BD2MXhtFGktrrK (Pubitemid 41500831)
58. P Xu AK Hall 2006 The role of activin in neuropeptide induction and pain sensation Dev Biol 299 303 309 10.1016/j.ydbio.2006.08.026 16973148 10.1016/j.ydbio.2006.08.026 1:CAS:528:DC%2BD28XhtFCjs7jL (Pubitemid 44635452)
59. P Xu AK Hall 2007 Activin acts with nerve growth factor to regulate calcitonin gene-related peptide mRNA in sensory neurons Neuroscience 150 665 674 10.1016/j.neuroscience.2007.09.041 17964731 10.1016/j.neuroscience.2007.09.041 1:CAS:528:DC%2BD2sXhsVWjtrbF (Pubitemid 350198735)
60. AM Salmon MI Damaj LM Marubio MP Epping-Jordan E Merlo-Pich JP Changeux 2001 Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice Nat Neurosci 4 357 358 10.1038/86001 11276224 10.1038/86001 1:CAS:528:DC%2BD3MXitlGqu7g%3D (Pubitemid 32260110)
61. Z Zhang CS Winborn B Marquez de Prado AF Russo 2007 Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion J Neurosci 27 2693 2703 10.1523/JNEUROSCI.4542-06.2007 17344407 10.1523/JNEUROSCI.4542-06.2007 1:CAS:528:DC%2BD2sXjsVCrtbc%3D (Pubitemid 46393588)
62. Hou Q, Barr T, Gee L, Vickers J, Wymer J, Borsani E, Rodella L, Getsios S, Burdo T, Eisenberg E, Guha U, Lavker R, Kessler J, Chittur S, Fiorino D, Rice F, Albrecht P. Keratinocyte expression of calcitonin gene-related peptide β: implications for neuropathic and inflammatory pain mechanisms. Pain 152:2036-2051. doi:10.1016/j.pain.2011.04.033
63. U Guha WA Gomes J Samanta M Gupta FL Rice JA Kessler 2004 Target-derived BMP signaling limits sensory neuron number and the extent of peripheral innervation in vivo Development 131 1175 1186 10.1242/dev.01013 14973275 10.1242/dev.01013 1:CAS:528:DC%2BD2cXis1ems7w%3D (Pubitemid 38380470)
64. G Hübner Q Hu H Smola S Werner 1996 Strong induction of activin expression after injury suggests an important role of activin in wound repair Dev Biol 173 490 498 10.1006/dbio.1996.0042 8606007 10.1006/dbio.1996.0042 (Pubitemid 26064869)
65. M Wankell B Munz G Hübner W Hans E Wolf A Goppelt S Werner 2001 Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis EMBO J 20 5361 5372 10.1093/emboj/20.19.5361 11574468 10.1093/emboj/20.19.5361 1:CAS:528:DC%2BD38XjtVSqsA%3D%3D (Pubitemid 32959456)
66. C Bamberger A Schärer M Antsiferova B Tychsen S Pankow M Müller T Rülicke R Paus S Werner 2005 Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes Am J Pathol 167 733 747 10.1016/S0002-9440(10)62047-0 16127153 10.1016/S0002-9440(10)62047-0 1:CAS:528:DC%2BD2MXhtVGmtr3E (Pubitemid 41216358)
67. M Antsiferova JE Klatte E Bodó R Paus JL Jorcano MM Matzuk S Werner H Kögel 2009 Keratinocyte-derived follistatin regulates epidermal homeostasis and wound repair Lab Invest 89 131 141 10.1038/labinvest.2008.120 19079322 10.1038/labinvest.2008.120 1:CAS:528:DC%2BD1MXhtVCnuro%3D
68. G Hübner Q Hu H Smola 1996 Werner S (1996) Strong induction of activin expression after injury suggests an important role of activin in wound repair Dev Biol 173 2 490 498 10.1006/dbio.1996.0042 8606007 10.1006/dbio.1996.0042 (Pubitemid 26064869)
69. S Sulyok M Wankell C Alzheimer S Werner 2004 Activin: an important regulator of wound repair, fibrosis, and neuroprotection Mol Cell Endocrinol 225 127 132 10.1016/j.mce.2004.07.011 15451577 10.1016/j.mce.2004.07.011 1:CAS:528:DC%2BD2cXnvV2murs%3D (Pubitemid 39297062)
70. L Zhang AO Hoff SJ Wimalawansa GJ Cote RF Gagel KN Westlund 2001 Arthritic calcitonin/alpha calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity Pain 89 265 273 10.1016/S0304-3959(00) 00378-X 11166483 10.1016/S0304-3959(00)00378-X 1:CAS:528:DC%2BD3MXpt1yltQ%3D%3D (Pubitemid 32146406)
71. S Benemei P Nicoletti JG Capone P Geppetti 2009 CGRP receptors in the control of pain and inflammation Curr Opin Pharmacol 9 9 14 10.1016/j.coph.2008. 12.007 19157980 10.1016/j.coph.2008.12.007 1:CAS:528:DC%2BD1MXhsFKks7o%3D
72. TW Ho L Edvinsson PJ Goadsby 2010 CGRP and its receptors provide new insights into migraine pathophysiology Nat Rev Neurol 6 573 582 10.1038/nrneurol.2010.127 20820195 10.1038/nrneurol.2010.127 1:CAS:528:DC%2BC3cXht1Gku7bI
73. JB Davis J Gray MJ Gunthorpe JP Hatcher PT Davey P Overend MH Harries J Latcham C Clapham K Atkinson SA Hughes K Rance E Grau AJ Harper PL Pugh DC Rogers S Bingham A Randall SA Sheardown 2000 Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia Nature 405 183 187 10.1038/35012076 10821274 10.1038/35012076 1:CAS:528:DC%2BD3cXjsFOqt70%3D (Pubitemid 30313536)
74. F Cervero JMA Laird 2004 Understanding the signaling and transmission of visceral nociceptive events J Neurobiol 61 45 54 10.1002/neu.20084 15362152 10.1002/neu.20084 1:CAS:528:DC%2BD2cXovVajtr8%3D (Pubitemid 39287769)
75. W Ma R Quirion 2007 Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain Expert Opin Ther Targets 11 307 320 10.1517/14728222.11.3.307 17298290 10.1517/14728222.11.3.307 (Pubitemid 46290955)
76. MJ Gunthorpe BA Chizh 2009 Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway Drug Discov Today 14 56 67 10.1016/j.drudis.2008.11.005 19063991 10.1016/j.drudis.2008.11.005 1:CAS:528:DC%2BD1MXktVShsA%3D%3D